PEDIATRICS Vol. 86 No. 2 August 1990, pp. 226-237
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pelham, W. E.
Right arrow Articles by Dahl, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pelham, W. E., Jr
Right arrow Articles by Dahl, R. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Relative Efficacy of Long-Acting Stimulants on Children With Attention Deficit-Hyperactivity Disorder: A Comparison of Standard Methylphenidate, Sustained-Release Methylphenidate, Sustained-Release Dextroamphetamine, and Pemoline

William E. Pelham Jr PhD1, Karen E. Greenslade 1, Mary Vodde-Hamilton 1, Debra A. Murphy PhD1, Jonathan J. Greenstein MS1, Elizabeth M. Gnagy 1, Karen J. Guthrie RN1, Michele D. Hoover MSN1, and Ronald E. Dahl MD1

1 From the Western Psychiatric Institute and Clinic, Pittsburgh, Pennsylvania

Twenty-two children with attention deficit-hyperactivity disorder underwent a double-blind, placebo-controlled, crossover evaluation of the efficacy of standard methylphenidate twice a day and comparable doses every morning of a sustained-release preparation of methylphenidate (SR-20 Ritalin), a sustained-release form of dextroamphetamine (Dexedrine Spansule), and pemoline. The children were participating in a summer treatment program in which they engaged in recreational and classroom activities. Dependent measures include evaluations of social behavior during group recreational activities, classroom performance, and performance on a continuous performance task. Results revealed generally equivalent and beneficial effects of all four medications. Dexedrine Spansule and pemoline tended to produce the most consistent effects and were recommended for 10 of the 15 children who were responders to medication. The continuous performance task results showed that all four medications had an effect within 2 hours of ingestion, and the effects lasted for 9 hours. The implications of these results for the use of long-acting stimulant medication in children with attention deficit-hyperactivity disorder are discussed.

Key Words: attention deficit-hyperactivity disorder • long-acting stimulant medication • methylphenidate • dextroamphetamine • pemoline

Submitted on April 12, 1989
Accepted on August 4, 1989


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 FocusHome page
L. L. Greenhill, S. Pliszka, M. K. Dulcan, W. Bernet, V. Arnold, J. Beitchman, R. S. Benson, O. Bukstein, J. Kinlan, J. McClellan, et al.
Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults
Focus, October 1, 2004; 2(4): 642 - 668.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
J. Swanson, S. Gupta, A. Lam, I. Shoulson, M. Lerner, N. Modi, E. Lindemulder, and S. Wigal
Development of a New Once-a-Day Formulation of Methylphenidate for the Treatment of Attention-deficit/Hyperactivity Disorder: Proof-of-Concept and Proof-of-Product Studies
Arch Gen Psychiatry, February 1, 2003; 60(2): 204 - 211.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Emotional and Behavioral DisordersHome page
K. E. McGoey, T. L. Eckert, and G. J. Dupaul
Early Intervention for Preschool-Age Children with ADHD: A Literature Review
Journal of Emotional and Behavioral Disorders, January 1, 2002; 10(1): 14 - 28.
[Abstract] [PDF]

Home page
 REVIEW OF EDUCATIONAL RESEARCHHome page
N. Purdie, J. Hattie, and A. Carroll
A Review of the Research on Interventions for Attention Deficit Hyperactivity Disorder: What Works Best?
Review of Educational Research, January 1, 2002; 72(1): 61 - 99.
[Abstract] [PDF]

Home page
 Arch Gen PsychiatryHome page
T. Spencer, J. Biederman, T. Wilens, S. Faraone, J. Prince, K. Gerard, R. Doyle, A. Parekh, J. Kagan, and S. K. Bearman
Efficacy of a Mixed Amphetamine Salts Compound in Adults With Attention-Deficit/Hyperactivity Disorder
Arch Gen Psychiatry, August 1, 2001; 58(8): 775 - 782.
[Abstract] [Full Text] [PDF]

Home page
 J. Neuropsychiatry Clin. Neurosi.Home page
C. A. Riccio, J. J.M. Waldrop, C. R. Reynolds, and P. Lowe
Effects of Stimulants on the Continuous Performance Test (CPT): Implications for CPT Use and Interpretation
J Neuropsychiatry Clin Neurosci, August 1, 2001; 13(3): 326 - 335.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. E. Pelham, E. M. Gnagy, L. Burrows-Maclean, A. Williams, G. A. Fabiano, S. M. Morrisey, A. M. Chronis, G. L. Forehand, C. A. Nguyen, M. T. Hoffman, et al.
Once-a-Day Concerta Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural Settings
Pediatrics, June 1, 2001; 107 (6): e105 - e105.
[Abstract] [Full Text] [PDF]

Home page
 J Atten DisordHome page
L. E. Arnold
Methyiphenidate vs. amphetamine: Comparative review
J Atten Disord, January 1, 2000; 3(4): 200 - 211.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
M. A. Kent, C. S. Camfield, and P. R. Camfield
Double-blind Methylphenidate Trials: Practical, Useful, and Highly Endorsed by Families
Arch Pediatr Adolesc Med, December 1, 1999; 153(12): 1292 - 1296.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
W. E. Pelham, E. M. Gnagy, A. M. Chronis, L. Burrows-MacLean, G. A. Fabiano, A. N. Onyango, D. L. Meichenbaum, A. Williams, H. R. Aronoff, and R. L. Steiner
A Comparison of Morning-Only and Morning/Late Afternoon Adderall to Morning-Only, Twice-Daily, and Three Times-Daily Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder
Pediatrics, December 1, 1999; 104(6): 1300 - 1311.
[Abstract] [Full Text]

Home page
 PediatricsHome page
W. E. Pelham, H. R. Aronoff, J. K. Midlam, C. J. Shapiro, E. M. Gnagy, A. M. Chronis, A. N. Onyango, G. Forehand, A. Nguyen, and J. Waxmonsky
A Comparison of Ritalin and Adderall: Efficacy and Time-course in Children With Attention-deficit/Hyperactivity Disorder
Pediatrics, April 1, 1999; 103(4): 43e - 43.
[Abstract] [Full Text]

Home page
 NEJMHome page
J. Elia, P. J. Ambrosini, and J. L. Rapoport
Treatment of Attention-Deficit-Hyperactivity Disorder
N. Engl. J. Med., March 11, 1999; 340(10): 780 - 788.
[Full Text] [PDF]

Home page
 J PsychopharmacolHome page
E. J. Garland
Reviews : Pharmacotherapy of adolescent attention deficit hyperactivity disorder: challenges, choices and caveats
J Psychopharmacol, January 1, 1998; 12(4): 385 - 395.
[Abstract] [PDF]

Home page
 PediatricsHome page
D. Efron, F. Jarman, and M. Barker
Methylphenidate Versus Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double-blind, Crossover Trial
Pediatrics, December 1, 1997; 100(6): e6 - e6.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
D. Efron, F. Jarman, and M. Barker
Side Effects of Methylphenidate and Dexamphetamine in Children With Attention Deficit Hyperactivity Disorder: A Double-blind, Crossover Trial
Pediatrics, October 1, 1997; 100(4): 662 - 666.
[Abstract] [Full Text] [PDF]

Home page
 J Am Psychiatr Nurses AssocHome page
C. A. Glod
Attention Deficit Hyperactivity Disorder Throughout the Lifespan: Diagnosis, Etiology, and Treatment
Journal of the American Psychiatric Nurses Association, June 1, 1997; 3(3): 89 - 92.
[PDF]

Home page
 Arch NeurolHome page
M. W. Geisler, M. Sliwinski, P. K. Coyle, D. M. Masur, C. Doscher, and L. B. Krupp
The Effects of Amantadine and Pemoline on Cognitive Functioning in Multiple Sclerosis
Arch Neurol, February 1, 1996; 53(2): 185 - 188.
[Abstract] [PDF]

Home page
 DTBHome page
The management of hyperactive children
DTB, August 1, 1995; 33(8): 57 - 60.
[Abstract] [Full Text] [PDF]

Home page
 Arch Fam MedHome page
D. C. Vinson
Therapy for Attention-Deficit Hyperactivity Disorder
Arch Fam Med, May 1, 1994; 3(5): 445 - 451.
[Abstract] [PDF]

Home page
 Arch Fam MedHome page
L. H. McCormick, G. T. Rizzuto, and H. B. Knuckles
A Pilot Study of Buspirone in Attention-Deficit Hyperactivity Disorder
Arch Fam Med, January 1, 1994; 3(1): 68 - 70.
[Abstract] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
J. Bowen, T. Fenton, and L. Rappaport
Stimulant Medication and Attention Deficit--Hyperactivity Disorder: The Child's Perspective
Arch Pediatr Adolesc Med, March 1, 1991; 145(3): 291 - 295.
[Abstract] [PDF]